Wharton ’s jelly mesenchymal stem cells transplantation for critical limb ischemia in patients with type 2 diabetes mellitus: a preliminary report of phase I clinical trial
In conclusion, allogeneic WJ-MSC transplantation in patients with CLI seems to be safe and effective.
Source: Cell and Tissue Research - Category: Cytology Source Type: research
More News: Clinical Trials | Cytology | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Disability | Endocrinology | Gastroenterology | Pain | Statistics | Stem Cell Therapy | Stem Cells | Transplants